176 related articles for article (PubMed ID: 29944896)
1. Human cathepsins K, L, and S: Related proteases, but unique fibrinolytic activity.
Douglas SA; Lamothe SE; Singleton TS; Averett RD; Platt MO
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1925-1932. PubMed ID: 29944896
[TBL] [Abstract][Full Text] [Related]
2. Computational predictions of cysteine cathepsin-mediated fibrinogen proteolysis.
Ferrall-Fairbanks MC; West DM; Douglas SA; Averett RD; Platt MO
Protein Sci; 2018 Mar; 27(3):714-724. PubMed ID: 29266558
[TBL] [Abstract][Full Text] [Related]
3. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.
Kolev K; Komorowicz E; Owen WG; Machovich R
Thromb Haemost; 1996 Jan; 75(1):140-6. PubMed ID: 8713793
[TBL] [Abstract][Full Text] [Related]
4. Multiplex Cathepsin Zymography to Detect Amounts of Active Cathepsins K, L, S, and V.
Platt MO
Methods Mol Biol; 2017; 1626():239-252. PubMed ID: 28608217
[TBL] [Abstract][Full Text] [Related]
5. Sequential, but not Concurrent, Incubation of Cathepsin K and L with Type I Collagen Results in Extended Proteolysis.
Parks AN; Nahata J; Edouard NE; Temenoff JS; Platt MO
Sci Rep; 2019 Apr; 9(1):5399. PubMed ID: 30931961
[TBL] [Abstract][Full Text] [Related]
6. Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues.
Wilder CL; Park KY; Keegan PM; Platt MO
Arch Biochem Biophys; 2011 Dec; 516(1):52-7. PubMed ID: 21982919
[TBL] [Abstract][Full Text] [Related]
7. The fibrin(ogen)olytic properties of cathepsin D.
Simon DI; Ezratty AM; Loscalzo J
Biochemistry; 1994 May; 33(21):6555-63. PubMed ID: 8204591
[TBL] [Abstract][Full Text] [Related]
8. Fasciola hepatica cathepsin L proteinase cleaves fibrinogen and produces a novel type of fibrin clot.
Dowd AJ; McGonigle S; Dalton JP
Eur J Biochem; 1995 Aug; 232(1):241-6. PubMed ID: 7556157
[TBL] [Abstract][Full Text] [Related]
9. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis.
Cone SJ; Fuquay AT; Litofsky JM; Dement TC; Carolan CA; Hudson NE
Acta Biomater; 2020 Apr; 107():164-177. PubMed ID: 32105833
[TBL] [Abstract][Full Text] [Related]
10. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.
Kolev K; Tenekedjiev K; Komorowicz E; Machovich R
J Biol Chem; 1997 May; 272(21):13666-75. PubMed ID: 9153217
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L.
Andrault PM; Samsonov SA; Weber G; Coquet L; Nazmi K; Bolscher JG; Lalmanach AC; Jouenne T; Brömme D; Pisabarro MT; Lalmanach G; Lecaille F
Biochemistry; 2015 May; 54(17):2785-98. PubMed ID: 25884905
[TBL] [Abstract][Full Text] [Related]
12. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
13. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
Plow EF; Edgington TS
J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte-endothelial cell signaling and JNK activation.
Keegan PM; Wilder CL; Platt MO
Mol Cell Biochem; 2012 Aug; 367(1-2):65-72. PubMed ID: 22562303
[TBL] [Abstract][Full Text] [Related]
15. The elastase-mediated pathway of fibrinolysis.
Machovich R; Owen WG
Blood Coagul Fibrinolysis; 1990; 1(1):79-90. PubMed ID: 2151710
[TBL] [Abstract][Full Text] [Related]
16. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor.
Coppini LP; Barros NM; Oliveira M; Hirata IY; Alves MF; Paschoalin T; Assis DM; Juliano MA; Puzer L; Brömme D; Carmona AK
Biol Chem; 2010 May; 391(5):561-70. PubMed ID: 20302511
[TBL] [Abstract][Full Text] [Related]
18. The Unusual Resistance of Avian Defensin AvBD7 to Proteolytic Enzymes Preserves Its Antibacterial Activity.
Bailleul G; Kravtzoff A; Joulin-Giet A; Lecaille F; Labas V; Meudal H; Loth K; Teixeira-Gomes AP; Gilbert FB; Coquet L; Jouenne T; Brömme D; Schouler C; Landon C; Lalmanach G; Lalmanach AC
PLoS One; 2016; 11(8):e0161573. PubMed ID: 27561012
[TBL] [Abstract][Full Text] [Related]
19. Fast profiling of protease specificity reveals similar substrate specificities for cathepsins K, L and S.
Vizovišek M; Vidmar R; Van Quickelberghe E; Impens F; Andjelković U; Sobotič B; Stoka V; Gevaert K; Turk B; Fonović M
Proteomics; 2015 Jul; 15(14):2479-90. PubMed ID: 25626674
[TBL] [Abstract][Full Text] [Related]
20. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
